Immune Monitor April 2017

A Message from the President


Dear Colleagues,

The Society for Immunotherapy of Cancer (SITC) on Monday, May 1 will launch SITC Cancer Immunotherapy connectED, its new online education tool for the greater cancer immunotherapy field. This education portal, part of SITC Cancer Immunotherapy CONNECT, provides educational resources and activities regarding current advances in cancer immunotherapy organized by stakeholder groups (patients, clinicians and researchers).

With the recent explosion of information related to cancer immunotherapy, there is a critical need for an unbiased educational resource destination where everyone can find the information they need, when they need it. SITC connectED will shape how we learn about cancer immunotherapy.

Utilizing a personalized learning system, SITC connectED identifies and delivers resources customized to each individual user. This portal highlights recent advances in the cancer immunotherapy field by providing educational activities using content from SITC and partner educational programs. SITC connectED bridges knowledge gaps by providing online educational opportunities in a convenient and easy to use platform.

Through SITC connectED, clinicians and patients can stay up-to-date on the most novel clinical applications of immunotherapy. Educational materials from live events will also be featured, allowing users to stay at the forefront of research in the immunotherapy field.

SITC connectED provides opportunities for medical professionals to earn continuing education credits (CME, CNE and CPE) and apply new concepts to clinical scenarios through engaging practice activities. Users will be able to utilize robust communication tools to share and collaborate with others in SITC CONNECT communities.

SITC connectED curates a variety of learning activities, including online classes, videos and webinars from world-renowned leaders in the field of cancer immunotherapy. This education portal will also provide opportunities for patients, caregivers and advocates to learn new information about the use of cancer immunotherapy to treat specific disease states.

Watch for an email on Monday providing a link to SITC connectED. I implore you all to experience this innovative learning portal.

Best wishes,

Dr-Butterfield_IM_Final.jpg








Lisa H. Butterfield, PhD

SITC President

Education


SITC 2017 – REGISTRATION NOW OPEN TO THE PUBLIC
November 8-12, 2017 • National Harbor, MD

ACI_Logo-IM_Final.jpgRegistration and housing for SITC’s 32nd Annual Meeting & Pre-Conference Programs is now open. Register now for this premier destination for scientific exchange, education and networking in the cancer immunotherapy field. SITC members receive up to a 20 percent savings on registration. Join SITC, renew your membership, or check your current membership status to take advantage of this discount!

Call for Abstracts – Submit Now Through August 1, 2017

Members and nonmembers are encouraged to submit regular and late-breaking abstract applications for the upcoming 32nd Annual Meeting. Introduce your research at SITC 2017 and present alongside luminaries in the cancer immunotherapy field. Submit your abstract to the largest conference solely dedicated to cancer immunotherapy before the submission deadline on August 1. Learn more and submit your abstract.

Did you know? SITC early career members who submit an abstract to SITC 2017 as both primary and presenting author are eligible for one of 32 SITC Young Investigator Awards. Join SITC, renew your membership, or check your current membership status to be eligible for these prestigious awards.


UPCOMING SITC EVENTS

Advances in Cancer Immunotherapy™ (ACI) – San Francisco, CA

Presented by the Society for Immunotherapy of Cancer in collaboration with the American Academy of Emergency Physicians and the Association of Community Cancer Centers

ACI_Online-IM_Final.jpgMay 6, 2017 • San Francisco, CA
Register now for this introductory program to gain a greater understanding of the mechanisms and clinical application of cancer immunotherapies, the management of adverse events and strategies to overcome operational and financial barriers to implementing immunotherapy. SITC members receive discounted registration rates. Advance registration ends April 28. Learn more and register.

The International Symposium on Immunotherapy

Presented by the Institute for Cancer Vaccines and Immunotherapy in collaboration with the Society for Immunotherapy of Cancer

May 12-13, 2017 • London, England
Leading immunotherapy experts will share their latest scientific findings on the opportunities and challenges that exist today in immunotherapy with an emphasis on combinations of chemotherapy and immunotherapy and various immunotherapy agents. Learn more and register.

Cancer Immunity & Immunotherapy

Presented by the Federation of Clinical Immunology Societies and the Society for Immunotherapy of Cancer


June 14, 2017 • Chicago, IL

This course will review tumor immunology as the foundation for the current practice of cancer immunotherapy emphasizing fundamental principles, recent clinical advances, current limitations and opportunities for furthering clinical progress. SITC members receive discounted registration rates. Learn more and register.

Incorporating Radiation Oncology into Immunotherapy

Presented by the American Society for Radiation Oncology in collaboration with the Society for Immunotherapy of Cancer

June 15-16, 2017 • Bethesda, MD
This workshop will cover many of the questions surrounding promising new approaches including the best combination, sequencing, dosages, timing of radiation and the use of valuable biomarkers in immunotherapy. SITC members receive discounted registration rates. Learn more and register.

Email education@sitcancer.org for more information on discounted registration rates.

 

Policy & Advocacy


SITC JOINS COALITION OF 20 ORGANIZATIONS CALLING FOR PRESERVATION OF NIH FUNDING

SITC signed on to a follow-up letter to the United States Congress and Senate opposing the Administration's budget proposal, reiterating the need for appropriate funding in cancer research while providing detailed rebuttals to the current proposal. Read the latest letter. SITC members are encouraged to contact their legislators to voice concerns about how these cuts could impact their research.

Did you know? Approximately 80 percent of NIH funding is used to conduct extramural research. Learn more about the advocacy and policy initiatives SITC participates in to promote cancer immunotherapy.


SITC LEADS THE CONVERSATION ON THE VALUE OF IMMUNOTHERAPY

A report from SITC's Value of Cancer Immunotherapy Summit, organized in collaboration with the American Society of Clinical Oncology (ASCO) as part of SITC’s 31st Annual Meeting & Associated Programs, was published in the April issue of the Journal for ImmunoTherapy of Cancer (JITC). The summit convened research scientists, academic physicians, industry professionals, health economists, third-party payers and patients to address current cancer therapy value models, economic outcomes of cancer therapy and the status of predictive biomarkers. Presentations from third-party payers, industry representatives, patient outcome experts and patient advocacy groups ensured that multiple perspectives were represented. This report p resents recommendations to better define the value of cancer immunotherapy for patients with cancer. Read the Meeting Report titled, “The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting,” as published in JITC.

Did you know? JITC’s article processing charges are waived for SITC members through 2017 – an incredible $2,500 value! Join SITC, renew your membership, or check your current membership status.


SITC UNITES WITH WORLD'S LEADING MEDICAL GROUPS IN SUPPORT OF SCIENCE

SITC joined the world’s leading organizations representing clinicians, laboratory researchers and physician-scientists committed to improving patient care in support of the March for Science and its nonpartisan call for the appreciation of scientific evidence, education and investment.

Issued by the American Society of Hematology (ASH), and signed on by 25 of the foremost medical organizations in the world, the press release acknowledges research supported by the National Institutes of Health (NIH) has yielded significant scientific advances and reiterates the critical need to preserve appropriate funding in cancer research.

 

Science, Research & Publications


SITC WORKSHOP PAVES THE WAY FOR STANDARDIZED IMMUNOTHERAPY TOXICITY MANAGEMENT

More than 80 participants, including oncology researchers, clinical practitioners, disease area specialists and industry representatives convened in Washington, D.C. for a one day Toxicity Management Workshop organized by SITC. The goals of the workshop were to gain consensus on how to standardize the management of immune checkpoint inhibitor toxicities and to standardize toxicity-related clinical trial protocol language. At the conclusion of this stimulating multidisciplinary meeting, oncologists and specialists in pulmonology, endocrinology, gastroenterology, dermatology, infusion reactions, rheumatology, nephrology, cardiology, neurology, hematology and ophthalmology arrived at treatment algorithms and clinical trial protocol languages for common and rare toxicities. These outcomes will be published in the Journal for ImmunoTherapy of Cancer (JITC) in the next few months.


SITC GIVES THANKS TO MORE THAN 200 PEER REVIEWERS IN 2016

jitc-logo.jpgMore than 200 reviewers volunteered their time to provide insightful comments that led to the successful publication of many diverse, high-quality manuscripts in the Journal for ImmunoTherapy of Cancer (JITC). The journal would not be thriving as it is without their thoughtful reviews and dedication. For this, everyone at SITC would like to extend their sincerest gratitude. If you are interested in serving as a JITC peer reviewer, please send your CV and a letter of interest to jitceditor@sitcancer.org.

Did you know? Each year, nearly 500 SITC volunteer members work to create everything you see and experience at educational events, society meetings and in publications. Join today to be eligible to serve on a SITC committee or task force.

 

 Membership

LEARN ABOUT NURSING PROFESSIONAL DEVELOPMENT WITH SITC AT ONS CONGRESS 2017

May 4-7, 2017 • Denver, CO
The countdown is approaching to the Oncology Nursing Society’s 42nd Annual Congress and SITC will take part as the leading member-driven organization specifically dedicated to cancer immunotherapy while networking and celebrating with more than 3,400 nurses.

Find SITC at Booth #222! Exciting opportunities await attendees who visit SITC staff. Those who create a user profile on SITC CONNECT will be entered into a drawing for a new iPad. Need to learn more about administering immunotherapies in your practice and possible adverse events? SITC has the resources.

Did you know? SITC members receive up to a 25 percent savings on registration rates to SITC’s Advances in Cancer Immunotherapy™ (ACI) CME-, CNE- and CE-certified live, regional education programs. Join SITC, renew your membership, or check your current membership status.

 
SITC BRINGS CANCER IMMUNOTHERAPY TO IMMUNOLOGY 2017

May 12-16, 2017 • Washington, D.C.
SITC will be in attendance among global scientific leaders from more than 40 countries in the tumor immunology and cancer immunotherapy space at the 2017 American Association of Immunologists Annual Meeting. Visit SITC at Booth #828 for information on the society’s Cancer Immunotherapy Guidelines, consensus statements published in the Journal for ImmunoTherapy of Cancer (JITC).

Did you know? Commenting during the development of the society’s Cancer Immunotherapy Guidelines is a benefit exclusive to members. Join SITC, renew your membership, or check your current membership status.


SITC WELCOMES 2017’S NEWEST MEMBERS

March 1-31, 2017

Join_SITC_IM.jpgThank you to those who joined the society in the month of March. If you are a SITC member, please welcome the following new members by sending a message of congratulations through the SITC CONNECT Member Directory:

Rafael Amado, MD
Philippe Armand, MD, PhD
Kurtis Bachman, PhD
Christine Bain
Andreas Behren, PhD
Ashely Cimino-Mathews, MD
Patricia Cornet, MA
Rituparna Das, PhD
Bruce L. Daugherty, PhD
Lazar Dimitrov, PhD
Jennifer Gansert, MD, PhD
Brooke M. Helfer, PhD
Jocelyn Holash, PhD
Josefin-Beate Holz, MD, PhD
Thomas Hudson, MD
Patrice Hugo, PhD
Ralf Huss, PhD
Salvatore Imperiale, MD
Dominic W. Lai, MD
Charles Morris, MD
Paul J. Neeson, PhD
Bilal Omer, MD
Claudia D. Onofrei, MD
Simarjot Pabla, PhD
Shiven B. Patel, MD
Deepa Rangachari, MD
Paula Rauschkolb, DO
Aideen E. Ryan, PhD
Josue Samayoa, PhD
Netta Rose Shraga
Cyndy Simonson, MS, APRN-BC, AOCN
Harald A. Weber, MD
Richard K. Yang, MD, PhD





 

Did you know? SITC members who recruit colleagues to join the society using the Connect-a-Colleague Tool become eligible for SITC’s 2017 Connect-a-Colleague Top Referrer award and receive recognition among their peers at the Annual Meeting. Join SITC, renew your membership, or check your current membership status.

 

Forward Fund


RESERVE YOUR VIP SPOT FOR THE CHECKPOINTS AT THE HOUSE OF BLUES CHICAGO

CheckPoints2016.jpgJune 4, 2017 • Chicago, IL
Don’t miss out on celebrating the latest innovations of young investigators in the cancer immunotherapy space with SITC’s very own house band, The CheckPoints. Enjoy hors d’oeuvres and dance the night away to celebrate SITC’s 33 years in cancer immunotherapy research and education.

Last year's concert sold out, so reserve your VIP spot today! Email development@sitcancer.org or call (414) 271-2456.

Did you know? The 2016 CheckPoints show at the House of Blues raised more than $70,000 to support early career scientists last year through the Forward Fund. Be the spark for innovation with a gift to the Forward Fund today.

 

sim-logo-v2.jpg Society


NEW TO SITC CONNECT

Connect-ConnectED(1).jpgPost Anonymously to SITC's Online Open Forum

SITC Cancer Immunotherapy CONNECT’s Open Forum has experienced a significant boost in use. The society has decided to continue this recent surge of momentum by providing SITC CONNECT users the ability to comment anonymously in the Open Forum. Learn more.

Members Only: Clinician/Researcher Community

SITC CONNECT launched a new community space specifically for society members in the Regular, Emeritus, Nurse and Physician Extender, Pharmacist and Student membership categories. Join SITC, renew your membership, or check your current membership status to join the conversation. This new Clinician/Researcher Community provides a dedicated location for conversations regarding the latest research, trends, news and professional experiences in the research and clinical use of cancer immunotherapy. Learn more.

Did you know? You don’t have to be a member to set up a free SITC CONNECT account today.


NOW HIRING – SITC SEEKS FULL-TIME MEDICAL WRITER WITH EXPERTISE IN IMMUNOLOGY AND/OR ONCOLOGY

SITC is hiring a full-time Medical Writer. The role can be fulfilled onsite in the Milwaukee, WI office; alternatively, a telecommuting arrangement will be considered for the right candidate. If you or someone you know is interested, view the full job description and apply, or forward this information to a qualified candidate in your network.

Did you know? SITC members from academic institutions save 25 percent on fees for posting to SITC’s Job Board on the SITC Cancer Immunotherapy CONNECT community website. Join SITC, renew your membership, or check your current membership status.